Found 790 results
Author Keyword [ Title(Asc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Orner GA, Roebuck BD, Dashwood RH, Bailey GS.  2006.  Post-initiation chlorophyllin exposure does not modulate aflatoxin-induced foci in the liver and colon of rats.. J Carcinog. 5:6.
Boulikas T.  1993.  Poly(ADP-ribosyl)ation, DNA strand breaks, chromatin and cancer.. Toxicol Lett. 67(1-3):129-50.
Boulikas T.  1992.  Poly(ADP-ribose) synthesis in blocked and damaged cells and its relation to carcinogenesis.. Anticancer Res. 12(3):885-98.
Boulikas T.  1992.  Poly(ADP-ribose) synthesis and degradation in mammalian nuclei.. Anal Biochem. 203(2):252-8.
Shoaib M, Choudhary RC, Choi J, Kim N, Hayashida K, Yagi T, Yin T, Nishikimi M, Stevens JF, Becker LB et al..  2020.  Plasma metabolomics supports the use of long-duration cardiac arrest rodent model to study human disease by demonstrating similar metabolic alterations.. Sci Rep. 10(1):19707.
Smith AR, Visioli F, Hagen TM.  2006.  Plasma membrane-associated endothelial nitric oxide synthase and activity in aging rat aortic vascular endothelia markedly decline with age.. Arch Biochem Biophys. 454(1):100-5.
Lindner JR, Davidson BP, Song Z, Maier CS, Minnier J, Stevens JFrederick, Ferencik M, Taqui S, J Belcik T, Moccetti F et al..  2021.  Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction.. Metabolites. 11(10)
Vasilevsky NA, Foster ED, Engelstad ME, Carmody L, Might M, Chambers C, Dawkins HJS, Lewis J, Rocca MGDella, Snyder M et al..  2018.  Plain-language medical vocabulary for precision diagnosis.. Nat Genet. 50(4):474-476.
Bobe G, Zhang Z, Kopp R, Garzotto M, Shannon J, Takata Y.  2020.  Phytol and its metabolites phytanic and pristanic acids for risk of cancer: current evidence and future directions.. Eur J Cancer Prev. 29(2):191-200.
Bobe G, Zhang Z, Kopp R, Garzotto M, Shannon J, Takata Y.  2020.  Phytol and its metabolites phytanic and pristanic acids for risk of cancer: current evidence and future directions.. Eur J Cancer Prev. 29(2):191-200.
Zheljazkov VD, Semerdjieva IB, Stevens JF, Wu W, Cantrell CL, Yankova-Tsvetkova E, Koleva-Valkova LH, Stoyanova A, Astatkie T.  2021.  Phytochemical Investigation and Reproductive Capacity of the Bulgarian Endemic Plant Species Boiss. (Lamiaceae).. Plants (Basel). 11(1)
Bading-Taika B, Akinyeke T, Magana AAlcazar, Choi J, Ouanesisouk M, Torres ERuth Samso, Lione LA, Maier CS, Bobe G, Raber J et al..  2018.  Phytochemical characterization of root bark and its effects on dysfunctional metabolism and cognitive performance in high-fat-fed C57BL/6J mice.. J Food Bioact. 3:111-123.
Miranda CL, Kumbi Y, Wu W, Lee H-S, Reed RL, Stevens JF.  2022.  Phytochemical characterization and bioactivity toward breast cancer cells of unhydrolyzed and acid-hydrolyzed extracts of .. Nat Prod Commun. 17(7)
Zheljazkov VD, Semerdjieva IB, Borisova D, Yankova-Tsvetkova E, Koleva-Valkova LH, Petrova G, Dincheva I, Stevens F, Wu W, Astatkie T et al..  2023.  Phytochemical and biological investigations on Centranthus kellereri (Stoj., Stef. & T. Georgiev) Stoj. & Stef. and C. ruber (L.) DC. and their potential as new medicinal and ornamental plants.. PLoS One. 18(11):e0293877.
Palomera-Sanchez Z, Watson GW, Wong CP, Beaver LM, Williams DE, Dashwood RH, Ho E.  2017.  The phytochemical 3,3'-diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells.. J Nutr Biochem. 47:113-119.
Carpenter EL, Le MN, Miranda CL, Reed RL, Stevens JF, Indra AK, Ganguli-Indra G.  2018.  Photoprotective Properties of Isothiocyanate and Nitrile Glucosinolate Derivatives From Meadowfoam () Against UVB Irradiation in Human Skin Equivalent.. Front Pharmacol. 9:477.
Al-Fageeh M, Li Q, W Dashwood M, Myzak MC, Dashwood RH.  2004.  Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32.. Oncogene. 23(28):4839-46.
Trias E, Díaz-Amarilla P, Olivera-Bravo S, Isasi E, Drechsel DA, Lopez N, C Bradford S, Ireton KE, Beckman JS, Barbeito L.  2013.  Phenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALS.. Front Cell Neurosci. 7:274.
Reveillaud I, Phillips J, Duyf B, Hilliker A, Kongpachith A, Fleming JE.  1994.  Phenotypic rescue by a bovine transgene in a Cu/Zn superoxide dismutase-null mutant of Drosophila melanogaster.. Mol Cell Biol. 14(2):1302-7.
Legette LC, Ma L, Reed RL, Miranda CL, Christensen JMark, Rodriguez-Proteau R, Stevens JF.  2012.  Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration.. Mol Nutr Food Res. 56(3):466-74.
Hummel JM, Madeen EP, Siddens LK, Uesugi SL, McQuistan T, Anderson KA, Turteltaub KW, Ognibene TJ, Bench G, Krueger SK et al..  2018.  Pharmacokinetics of [C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction.. Food Chem Toxicol. 115:136-147.
Fança-Berthon P, Tenon M, Le Bouter-Banon S, Manfré A, Maudet C, Dion A, Chevallier H, Laval J, van Breemen RB.  2021.  Pharmacokinetics of a Single Dose of Turmeric Curcuminoids Depends on Formulation: Results of a Human Crossover Study.. J Nutr.
Wright KM, Bollen M, David J, Speers AB, Brandes MS, Gray NE, Magana AAlcazar, McClure C, Stevens JF, Maier CS et al..  2022.  Pharmacokinetics and Pharmacodynamics of Key Components of a Standardized Product in Cognitively Impaired Older Adults: A Phase 1, Double-Blind, Randomized Clinical Trial.. Antioxidants (Basel). 11(2)
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Liu J, Banuvar S, Viana M, Barengolts E, Chen S-N, Pauli GF, van Breemen RB.  2023.  Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants.. Drug Metab Dispos. 51(2):199-204.